Health, Medical & Pharma News - Updated Daily page 142

FDA Says Drug Makers Will Stop Producing Fentanyl 'Lollipops'

Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug Administration has announced. Known as TIRF

Stroke Rates Rising in Adults and Kids With Sickle Cell Disease

Stroke rates continue to rise among adults and children living with sickle cell disease, despite new standards of care meant to lower their risk, a new study fi

Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer

Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk muscle-invasive urothelial carcinoma af

High Levels of Well-Being Protect Against Cardiovascular Disease

High levels of well-being may protect against the risks for cardiovascular diseases (CVDs), according to a study published online Sept. 18 in the Journal of the

FDA Approves First Flu Vaccine You Give Yourself at Home

The days of waiting for a flu shot at your doctor s office or local pharmacy may be over The U.S. Food and Drug Administration on Friday approved FluMist nasal

FDA Approves First Flu Vaccine That Can Be Self-Administered at Home

On Friday, the U.S. Food and Drug Administration approved the FluMist nasal vaccine for self-administration at home. It is a new option for receiving a safe and

No Perinatal Risks Seen With Influenza Vaccination in Successive Pregnancies

Influenza vaccination in successive pregnancies is not associated with increased risk for prespecified adverse perinatal outcomes, according to a study publishe

Stroke Was Third Most Common GBD Level 3 Cause of Death in 2021

The global burden of stroke is considerable, according to a study published in the October issue of The Lancet Neurology. Valery L. Feigin, M.D., Ph.D., from th

Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer

For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab yields a significant

Improvement Seen in Vaccine Completion Among Military Children

Among military children, there has been an improvement in vaccine completion and timeliness, but the risk for noncompletion is higher among children born to you

Pharmaceutical News and Articles